A systems approach to prion disease

Molecular Systems Biology

Volumn 5, Issue , 2009, Pages

  Hwang, Daehee ^a,b   Lee, Inyoul Y ^a   Yoo, Hyuntae ^a   Gehlenborg, Nils ^a,c   Cho, Ji Hoon ^b   Petritis, Brianne ^a   Baxter, David ^a   Pitstick, Rose ^d   Young, Rebecca ^d   Spicer, Doug ^d   Price, Nathan D ^g   Hohmann, John G ^e   DeArmond, Stephen J ^f   Carlson, George A ^d   Hood, Leroy E ^a  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^d MCLAUGHLIN RESEARCH INSTITUTE   (United States)

^e ALLEN INSTITUTE FOR BRAIN SCIENCE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Microarray; Network analysis; Neurodegenerative disease; Prion

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEGENERATIVE DISEASE; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION; GENE MAPPING; GENE REPLICATION; INCUBATION TIME; MOUSE; MOUSE STRAIN; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; VIRUS REPLICATION; ANIMAL; ASTROCYTE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MICROGLIA; PATHOLOGY; SYSTEMS BIOLOGY; TIME; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MICE; MICE, TRANSGENIC; MICROGLIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRION DISEASES; PRPSC PROTEINS; SYSTEMS BIOLOGY; TIME FACTORS;

EID: 63149151206     PISSN: 17444292     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb.2009.10     Document Type: Article

References (98)

1. Baranano DE, Rao M, Ferris CD, Snyder SH (2002) Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99: 16093-16098
2. Basu S, Mohan ML, Luo X, Kundu B, Kong Q, Singh N (2007) Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis. Mol Biol Cell 18: 3302-3312
3. Baumann F, Tolnay M, Brabeck C, Pahnke J, Kloz U, Niemann HH, Heikenwalder M, Rulicke T, Burkle A, Aguzzi A (2007) Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J 26: 538-547
4. Ben-Zaken O, Tzaban S, Tal Y, Horonchik L, Esko JD, Vlodavsky I, Taraboulos A (2003) Cellular heparan sulfate participates in the metabolism of prions. J Biol Chem 278: 40041-40049
5. Berriz GF, King OD, Bryant B, Sander C, Roth FP (2003) Characterizing gene sets with FuncAssociate. Bioinformatics 19: 2502-2504
6. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8: 57-69
7. Booth S, Bowman C, Baumgartner R, Sorensen G, Robertson C, Coulthart M, Phillipson C, Somorjai RL (2004) Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection. J Gen Virol 85: 3459-3471
8. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA (2004) Molecular pathways to neurodegeneration. Nat Med 10 (Suppl): S2-S9
9. Bouzamondo-Bernstein E, Hopkins SD, Spilman P, Uyehara-Lock J, Deering C, Safar J, Prusiner SB, Ralston III HJ, DeArmond SJ (2004) The neurodegeneration sequence in prion diseases: evidence from functional, morphological and ultrastructural studies of the GABAergic system. J Neuropathol Exp Neurol 63: 882-899
10. Bouzamondo E, Milroy AM, Ralston III HJ, Prusiner SB, DeArmond SJ (2000) Selective neuronal vulnerability during experimental scrapie infection: insights from an ultrastructural investigation. Brain Res 874: 210-215
11. Brown AR, Rebus S, McKimmie CS, Robertson K, Williams A, Fazakerley JK (2005) Gene expression profiling of the preclinical scrapie-infected hippocampus. Biochem Biophys Res Commun 334: 86-95
12. Brown DR (2001) Microglia and prion disease. Microsc Res Tech 54: 71-80
13. Brown HC, Castano A, Fearn S, Townsend M, Edwards G, Streuli C, Perry VH (1997) Adhesion molecules involved in macrophage responses to Wallerian degeneration in the murine peripheral nervous system. Eur J Neurosci 9: 2057-2063
14. Bruce ME, McBride PA, Jeffrey M, Scott JR (1994) PrP in pathology and pathogenesis in scrapie-infected mice. Mol Neurobiol 8: 105-112
15. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347
16. Bueler H, Raeber A, Sailer A, Fischer M, Aguzzi A, Weissmann C (1994) High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol Med 1: 19-30
17. Carlson GA, Ebeling C, Torchia M, Westaway D, Prusiner SB (1993) Delimiting the location of the scrapie prion incubation time gene on chromosome 2 of the mouse. Genetics 133: 979-988
18. Carlson GA, Ebeling C, Yang SL, Telling G, Torchia M, Groth D, Westaway D, DeArmond SJ, Prusiner SB (1994) Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci USA 91: 5690-5694
19. Chasseigneaux S, Pastore M, Britton-Davidian J, Manie E, Stern MH, Callebert J, Catalan J, Casanova D, Belondrade M, Provansal M, Zhang Y, Burkle A, Laplanche JL, Sevenet N, Lehmann S (2008) Genetic heterogeneity versus molecular analysis of prion susceptibility in neuroblasma N2a sublines. Arch Virol 153: 1693-1702
20. Chesebro B, Race R, Wehrly K, Nishio J, Bloom M, Lechner D, Bergstrom S, Robbins K, Mayer L, Keith JM, Garon C, Haase A (1985) Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature 315: 331-333
21. Connor JR, Menzies SL (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17: 83-93
22. Dandoy-Dron F, Guillo F, Benboudjema L, Deslys JP, Lasmezas C, Dormont D, Tovey MG, Dron M (1998) Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts. J Biol Chem 273: 7691-7697
23. Deininger MH, Bekure-Nemariam K, Trautmann K, Morgalla M, Meyermann R, Schluesener HJ (2003) Cyclooxygenase-1 and -2 in brains of patients who died with sporadic Creutzfeldt-Jakob disease. J Mol Neurosci 20: 25-30
24. Engelstein R, Ovadia H, Gabizon R (2007) Copaxone interferes with the PrP Sc-GAG interaction. Eur J Neurol 14: 877-884
25. Friedman JH, Stuetzle W (1982) Projection pursuit methods for data analysis. In Modern Data Analysis. New York: Academic Press
26. Gabizon R, Meiner Z, Halimi M, Ben-Sasson SA (1993) Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate. J Cell Physiol 157: 319-325
27. Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretzschmar HA (1998) Role of microglia in neuronal cell death in prion disease. Brain Pathol 8: 449-457
28. Giri RK, Young R, Pitstick R, DeArmond SJ, Prusiner SB, Carlson GA (2006) Prion infection of mouse neurospheres. Proc Natl Acad Sci USA 103: 3875-3880
29. Glatzel M, Stoeck K, Seeger H, Luhrs T, Aguzzi A (2005) Human prion diseases: molecular and clinical aspects. Arch Neurol 62: 545-552
30. Guentchev M, Groschup MH, Kordek R, Liberski PP, Budka H (1998) Severe, early and selective loss of a subpopulation of GABAergic inhibitory neurons in experimental transmissible spongiform encephalopathies. Brain Pathol 8: 615-623
31. Guentchev M, Hainfellner JA, Trabattoni GR, Budka H (1997) Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 56: 1119-1124
32. Guentchev M, Wanschitz J, Voigtlander T, Flicker H, Budka H (1999) Selective neuronal vulnerability in human prion diseases. Fatal familial insomnia differs from other types of prion diseases. Am J Pathol 155: 1453-1457
33. Hijazi N, Kariv-Inbal Z, Gasset M, Gabizon R (2005) PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. J Biol Chem 280: 17057-17061
34. Hood L, Heath JR, Phelps ME, Lin B (2004) Systems biology and new technologies enable predictive and preventative medicine. Science 306: 640-643
35. Horonchik L, Tzaban S, Ben-Zaken O, Yedidia Y, Rouvinski A, Papy-Garcia D, Barritault D, Vlodavsky I, Taraboulos A (2005) Heparan sulfate is a cellular receptor for purified infectious prions. J Biol Chem 280: 17062-17067
36. Hwang D, Rust AG, Ramsey S, Smith JJ, Leslie DM, Weston AD, de Atauri P, Aitchison JD, Hood L, Siegel AF, Bolouri H (2005) A data integration methodology for systems biology. Proc Natl Acad Sci USA 102: 17296-17301
37. Imamura Y, Katahira T, Kitamura D (2004) Identification and characterization of a novel BASH N terminus-associated protein, BNAS2. J Biol Chem 279: 26425-26432
38. Ishikura N, Clever JL, Bouzamondo-Bernstein E, Samayoa E, Prusiner SB, Huang EJ, DeArmond SJ (2005) Notch-1 activation and dendritic atrophy in prion disease. Proc Natl Acad Sci USA 102: 886-891
39. Jeffrey M, Halliday WG, Bell J, Johnston AR, MacLeod NK, Ingham C, Sayers AR, Brown DA, Fraser JR (2000) Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol 26: 41-54
40. Jensen MB, Gonzalez B, Castellano B, Zimmer J (1994) Microglial and astroglial reactions to anterograde axonal degeneration: a histochemical and immunocytochemical study of the adult rat fascia dentata after entorhinal perforant path lesions. Exp Brain Res 98: 245-260
41. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, Cohen FE, Prusiner SB (1997) Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA 94: 10069-10074
42. Kikuta Y, Kasyu H, Kusunose E, Kusunose M (2000) Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. Arch Biochem Biophys 383: 225-232
43. Kim NH, Park SJ, Jin JK, Kwon MS, Choi EK, Carp RI, Kim YS (2000) Increased ferric iron content and iron-induced oxidative stress in the brains of scrapie-infected mice. Brain Res 884: 98-103
44. Klein MA, Kaeser PS, Schwarz P, Weyd H, Xenarios I, Zinkernagel RM, Carroll MC, Verbeek JS, Botto M, Walport MJ, Molina H, Kalinke U, Acha-Orbea H, Aguzzi A (2001) Complement facilitates early prion pathogenesis. Nat Med 7: 488-492
45. Klein TR, Kirsch D, Kaufmann R, Riesner D (1998) Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometry. Biol Chem 379: 655-666
46. Klingenstein R, Lober S, Kujala P, Godsave S, Leliveld SR, Gmeiner P, Peters PJ, Korth C (2006) Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments. J Neurochem 98: 748-759
47. Kristensson K, Feuerstein B, Taraboulos A, Hyun WC, Prusiner SB, DeArmond SJ (1993) Scrapie prions alter receptor-mediated calcium responses in cultured cells. Neurology 43: 2335-2341
48. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, Chen L, Chen L, Chen TM, Chin MC, Chong J, Crook BE, Czaplinska A, Dang CN, Datta S, Dee NR et al (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445: 168-176
49. Liberski PP, Sikorska B, Bratosiewicz-Wasik J, Gajdusek DC, Brown P (2004) Neuronal cell death in transmissible spongiform encephalopathies (prion diseases) revisited: from apoptosis to autophagy. Int J Biochem Cell Biol 36: 2473-2490
50. Lloyd SE, Onwuazor ON, Beck JA, Mallinson G, Farrall M, Targonski P, Collinge J, Fisher EM (2001) Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci USA 98: 6279-6283
51. Manolakou K, Beaton J, McConnell I, Farquar C, Manson J, Hastie ND, Bruce M, Jackson IJ (2001) Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc Natl Acad Sci USA 98: 7402-7407
52. Manson JC, Clarke AR, McBride PA, McConnell I, Hope J (1994) PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3: 331-340
53. Mayer-Sonnenfeld T, Avrahami D, Friedman-Levi Y, Gabizon R (2008) Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time. Cell Mol Neurobiol 28: 1005-1015
54. Mayer-Sonnenfeld T, Zeigler M, Halimi M, Dayan Y, Herzog C, Lasmezas CI, Gabizon R (2005) The metabolism of glycosaminoglycans is impaired in prion diseases. Neurobiol Dis 20: 738-743
55. Moreno CR, Lantier F, Lantier I, Sarradin P, Elsen JM (2003) Detection of new quantitative trait loci for susceptibility to transmissible spongiform encephalopathies in mice. Genetics 165: 2085-2091
56. Moscarello MA, Mastronardi FG, Wood DD (2007) The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res 32: 251-256
57. Na YJ, Jin JK, Kim JI, Choi EK, Carp RI, Kim YS (2007) JAK-STAT signaling pathway mediates astrogliosis in brains of scrapie-infected mice. J Neurochem 103: 637-649
58. Nakamura Y (2002) Regulating factors for microglial activation. Biol Pharm Bull 25: 945-953
59. Ohno M, Aotani H, Shimada M (1995) Glial responses to hypoxic/ischemic encephalopathy in neonatal rat cerebrum. Brain Res Dev Brain Res 84: 294-298
60. Ohya W, Funakoshi H, Kurosawa T, Nakamura T (2007) Hepatocyte growth factor (HGF) promotes oligodendrocyte progenitor cell proliferation and inhibits its differentiation during postnatal development in the rat. Brain Res 1147: 51-65
61. Ortiz E, Pasquini JM, Thompson K, Felt B, Butkus G, Beard J, Connor JR (2004) Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 77: 681-689
62. Panickar KS, Norenberg MD (2005) Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 50: 287-298
63. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M (2006) Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27: 402-409
64. Papadopoulos V, Brown AS (1995) Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis. J Steroid Biochem Mol Biol 53: 103-110
65. Perry VH, Cunningham C, Boche D (2002) Atypical inflammation in the central nervous system in prion disease. Curr Opin Neurol 15: 349-354
66. Pikas DS, Li JP, Vlodavsky I, Lindahl U (1998) Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem 273: 18770-18777
67. Plant SR, Wang Y, Vasseur S, Thrash JC, McMahon EJ, Bergstralh DT, Arnett HA, Miller SD, Carson MJ, Iovanna JL, Ting JP (2006) Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues. Glia 53: 529-537
68. Price ND, Edelman LB, Lee IY, Yoo H, Hwang D, Carlson GA, Galas DJ, Heath JR, Hood L (2008) Systems biology and systems medicine. In Genomic and Personalized Medicine: from Principles to Practice, Ginsburg G, Willard H (eds), Vol. 1, pp 74-85. New York: Elsevier
69. Priller J, Prinz M, Heikenwalder M, Zeller N, Schwarz P, Heppner FL, Aguzzi A (2006) Early and rapid engraftment of bone marrow-derived microglia in scrapie. J Neurosci 26: 11753-11762
70. Prusiner SB (2003) An introduction to prion biology and disease. In Prion Biology and Diseases, 2nd edn, pp 1-88. Cold Spring Harbor: Cold Spring Harbor Laboratory Press
71. Prusiner SB, Kingsbury DT (1985) Prions - infectious pathogens causing the spongiform encephalopathies. CRC Crit Rev Clin Neurobiol 1: 181-200
72. Rakonjac M, Fischer L, Provost P, Werz O, Steinhilber D, Samuelsson B, Radmark O (2006) Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production. Proc Natl Acad Sci USA 103: 13150-13155
73. Rezaie P, Lantos PL (2001) Microglia and the pathogenesis of spongiform encephalopathies. Brain Res Brain Res Rev 35: 55-72
74. Riemer C, Neidhold S, Burwinkel M, Schwarz A, Schultz J, Kratzschmar J, Monning U, Baier M (2004) Gene expression profiling of scrapie-infected brain tissue. Biochem Biophys Res Commun 323: 556-564
75. Rodriguez-Agudo D, Ren S, Wong E, Marques D, Redford K, Gil G, Hylemon P, Pandak WM (2008) Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation. J Lipid Res 49: 1409-1419
76. Saa P, Castilla J, Soto C (2006) Presymptomatic detection of prions in blood. Science 313: 92-94
77. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB (1998) Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4: 1157-1165
78. Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E, Prusiner SB, Tremblay P (2005) Prion clearance in bigenic mice. J Gen Virol 86: 2913-2923
79. Sim RB, Kishore U, Villiers CL, Marche PN, Mitchell DA (2007) C1q binding and complement activation by prions and amyloids. Immunology 212: 355-362
80. Simons K, Ehehalt R (2002) Cholesterol, lipid rafts, and disease. J Clin Invest 110: 597-603
81. Skinner PJ, Abbassi H, Chesebro B, Race RE, Reilly C, Haase AT (2006) Gene expression alterations in brains of mice infected with three strains of scrapie. BMC Genomics 7: 114
82. Sorensen G, Medina S, Parchaliuk D, Phillipson C, Robertson C, Booth SA (2008) Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes. BMC Genomics 9: 114
83. Soto C (2004) Diagnosing prion diseases: needs, challenges and hopes. Nat Rev Microbiol 2: 809-819
84. Soto C, Anderes L, Suardi S, Cardone F, Castilla J, Frossard MJ, Peano S, Saa P, Limido L, Carbonatto M, Ironside J, Torres JM, Pocchiari M, Tagliavini F (2005) Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 579: 638-642
85. Spires TL, Hannan AJ (2007) Molecular mechanisms mediating pathological plasticity in Huntington's disease and Alzheimer's disease. J Neurochem 100: 874-882
86. Stephenson DA, Chiotti K, Ebeling C, Groth D, DeArmond SJ, Prusiner SB, Carlson GA (2000) Quantitative trait loci affecting prion incubation time in mice. Genomics 69: 47-53
87. Vey M, Pilkuhn S, Wille H, Nixon R, DeArmond SJ, Smart EJ, Anderson RG, Taraboulos A, Prusiner SB (1996) Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci USA 93: 14945-14949
88. Walis A, Liberski PP, Brown P (2004) Ultrastructural alterations in the optic nerve in transmissible spongiform encephalopathies or prion diseases - a review. Folia Neuropathol 42 (Suppl B): 153-160
89. Wang M, Kong Q, Gonzalez FA, Sun G, Erb L, Seye C, Weisman GA (2005) P2Y nucleotide receptor interaction with alpha integrin mediates astrocyte migration. J Neurochem 95: 630-640
90. Wang Y, Li T, Qiu X, Mo X, Zhang Y, Song Q, Ma D, Han W (2008) CMTM3 can affect the transcription activity of androgen receptor and inhibit the expression level of PSA in LNCaP cells. Biochem Biophys Res Commun 371: 54-58
91. Watts JC, Drisaldi B, Ng V, Yang J, Strome B, Horne P, Sy MS, Yoong L, Young R, Mastrangelo P, Bergeron C, Fraser PE, Carlson GA, Mount HT, Schmitt-Ulms G, Westaway D (2007) The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections. EMBO J 26: 4038-4050
92. Westaway D, Goodman PA, Mirenda CA, McKinley MP, Carlson GA, Prusiner SB (1987) Distinct prion proteins in short and long scrapie incubation period mice. Cell 51: 651-662
93. Williams A, Lucassen PJ, Ritchie D, Bruce M (1997) PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol 144: 433-438
94. Wojtera M, Sikorska B, Sobow T, Liberski PP (2005) Microglial cells in neurodegenerative disorders. Folia Neuropathol 43: 311-321
95. Wong K, Qiu Y, Hyun W, Nixon R, VanCleff J, Sanchez-Salazar J, Prusiner SB, DeArmond SJ (1996) Decreased receptor-mediated calcium response in prion-infected cells correlates with decreased membrane fluidity and IP3 release. Neurology 47: 741-750
96. Xiang W, Hummel M, Mitteregger G, Pace C, Windl O, Mansmann U, Kretzschmar HA (2007) Transcriptome analysis reveals altered cholesterol metabolism during the neurodegeneration in mouse scrapie model. J Neurochem 102: 834-847
97. Xiang W, Windl O, Wunsch G, Dugas M, Kohlmann A, Dierkes N, Westner IM, Kretzschmar HA (2004) Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J Virol 78: 11051-11060
98. Zhang Y, Spiess E, Groschup MH, Burkle A (2003) Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells. J Gen Virol 84: 2279-2283